U.S. Healthcare Services Stock News

NYSE:OI
NYSE:OIPackaging

O I Glass (OI) Invests In Muskogee Upgrade On A Fair Value Debate

O-I Glass (OI) has announced an investment to upgrade the furnace and manufacturing equipment at its Muskogee, Oklahoma, plant, supported by a $2 million award from the Oklahoma Department of Commerce. For investors, this investment comes after a tough stretch for O-I Glass, with the share price down 53.7% year to date and the 1-year total shareholder return falling 45.2%. The 3-year total shareholder return has declined 63.9%, suggesting sentiment has weakened despite recent operational...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

How F5’s Expanded AI Security Features Could Reshape Its Role for Investors (FFIV)

F5 recently announced enhancements to its AI-powered web application firewall and virtual patching tools, adding anomaly detection, agentic threat intelligence, and tighter integration across its Distributed Cloud and BIG-IP platforms to help customers counter emerging AI-driven and zero-day threats in real time. A key implication is that F5 is embedding more self-learning, inline machine learning and automated virtual patching directly into its application delivery footprint, potentially...
NYSE:AXS
NYSE:AXSInsurance

Did AXIS Capital’s Q2 Earnings Miss Just Shift AXIS Capital Holdings’ (AXS) Investment Narrative?

In the past quarter, AXIS Capital Holdings reported Q2 results that fell short of analyst expectations on revenue, net premiums earned, and EPS, reflecting a weaker-than-anticipated performance. The underwhelming quarter highlights how sensitive AXIS remains to broader reinsurance sector conditions, where earnings can swing with catastrophe losses and capital flows. Next, we will examine how AXIS’s Q2 earnings miss may influence its investment narrative built around specialty insurance...
NYSE:DVA
NYSE:DVAHealthcare

DaVita (DVA) Expands Humana Partnership, Is The Stock Still Undervalued?

DaVita (DVA) has entered a new value based care agreement with Humana to manage Medicare Advantage members with earlier stage chronic kidney disease, extending their existing partnership beyond end stage care. Against this backdrop, DaVita’s share price has eased in the short term, with a 30 day share price return of down 26.64%. However, the year to date share price return is 53.82% and the 3 year total shareholder return is 82.25%, suggesting that longer term momentum remains stronger than...
NasdaqGS:MIDD
NasdaqGS:MIDDMachinery

Will Middleby's (MIDD) Spin-Off and Buybacks Shift How Investors Value Its Core Business?

Riverwater Partners has recently taken a stake in The Middleby Corporation after the company reported its strongest organic growth in two years, announced a planned spin-off of its food processing business, and repurchased nearly 5% of its shares outstanding in a single quarter. This combination of portfolio reshaping and aggressive buybacks is reshuffling how investors think about the value of Middleby’s core operations versus its food processing arm. We’ll now examine how the planned food...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Brookfield Infrastructure Partners (BIP) After Its Dividend Declaration And The Undervalued Narrative

Dividend announcement puts income focus on Brookfield Infrastructure Partners Brookfield Infrastructure Partners (NYSE:BIP) recently declared a total dividend of US$0.46 per unit, with an ex dividend date of 31 August 2026, drawing attention to the stock’s income profile for unitholders. Brookfield Infrastructure Partners’ recent dividend news comes as the stock trades at US$37.11, after the share price declined 11.14% over the past 30 days and 4.40% over 90 days, while total shareholder...
NYSE:RMD
NYSE:RMDMedical Equipment

Is ResMed (RMD) Below Fair Value On The MatrixCare Sale?

ResMed (RMD) is back in focus after Frazier Healthcare Partners completed its acquisition of MatrixCare, the company’s residential care software subsidiary, with Jonathan Lujan appointed as MatrixCare’s new chief executive officer. ResMed’s latest move comes after a mixed year for investors, with the share price down 5.49% year to date but showing a 24.08% 90 day share price return and a 54.84% total shareholder return over three years. However, the one year total shareholder return declined...
NasdaqGS:KURA
NasdaqGS:KURABiotechs

Is Kura Oncology's (KURA) Zacks Upgrade Quietly Reframing Its Precision Oncology Risk‑Reward Story?

Kura Oncology recently announced that management will present at three major September 2026 healthcare investor conferences, while continuing to develop precision oncology therapies including FDA-approved KOMZIFTI (ziftomenib) for relapsed or refractory NPM1-mutated acute myeloid leukemia. A recent upgrade of Kura Oncology to a Zacks Rank #2, driven by rising earnings estimates, highlights shifting analyst expectations for its business outlook. We’ll now examine how the Zacks...
NYSE:MC
NYSE:MCCapital Markets

3 U.S. M&A Advisor Stocks Built For Higher Rates

With the Fed funds rate still in the 3.50% to 3.75% range and banks keeping a tighter grip on lending, dealmaking is tilting toward buyers and advisors that can handle higher financing costs and focus on resilient cash flow. That shift is creating a fresh set of potential winners and laggards. This article profiles 3 U.S. Middle-Market M&A Advisors and Deal Services stocks that appear most exposed to these trends. The stocks covered below are just a starting sample, and the full screen...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Does Rusfertide Royalty Deal And Guidance Upgrade Change The Bull Case For Royalty Pharma (RPRX)?

Royalty Pharma recently agreed to pay Zealand Pharma US$100,000,000 for rights to future royalties and milestones tied to rusfertide, an experimental polycythemia vera treatment with an FDA decision previously guided for the third quarter of 2026. This deal adds a new late-stage, specialty-therapy royalty stream to Royalty Pharma’s portfolio, aligning with its focus on broadening exposure to innovative, high‑value medicines. We’ll now examine how acquiring future rusfertide royalties,...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Can Flywire (FLYW) Turn Niche Travel Partnerships Into Durable Payments-Market Advantage?

In August 2026, Travelling The Fairways International Ltd. announced it had chosen Flywire as its exclusive payments partner across its UK and Ireland golf tour operations, using Flywire’s platform to handle multi-currency, cross-border guest payments and improve transparency for international golfers. The deal highlights how Flywire’s sector-focused payments software can replace large general-purpose processors by cutting costs, simplifying tax reporting, and enhancing the experience for...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

Did Alleged Undisclosed Discounting Just Shift PROCEPT BioRobotics' (PRCT) Investment Narrative?

In recent months, multiple law firms have filed securities class action lawsuits against PROCEPT BioRobotics, alleging that undisclosed discounting programs inflated reported handpiece sales, revenues, and customer inventory levels between February 2024 and February 2026. The core allegation is that late-quarter bulk discounts pulled future demand forward and were not fully disclosed to investors, raising fresh questions about the quality and sustainability of the company’s reported growth...
NYSE:PK
NYSE:PKHotel and Resort REITs

Does Park Hotels & Resorts' (PK) New Loan And Upgrade Redefine Its Balance Sheet Playbook?

In late August and early September 2026, BMO Capital Markets upgraded Park Hotels & Resorts after the lodging REIT reported stronger-than-expected second-quarter results and arranged a US$700 million delayed draw loan facility to help manage upcoming debt maturities. The upgrade highlights how recent portfolio changes and balance sheet actions are reshaping perceptions of Park Hotels & Resorts’ future resilience and flexibility. Next, we’ll examine how the upgraded rating, backed by stronger...
NasdaqGS:ATAT
NasdaqGS:ATATHospitality

Is Atour Lifestyle Holdings (ATAT) Cheap On Strong 2026 Earnings And Revenue Guidance?

Why Atour Lifestyle Holdings stock is back in focus Atour Lifestyle Holdings (NasdaqGS:ATAT) is back on investors' radar after its latest quarterly report and new 2026 revenue guidance, which together offer fresh detail on the company's growth expectations. The company reported second quarter 2026 revenue of CNY 3,490.35 million and net income of CNY 547.72 million. It also issued guidance that points to a 30% increase in total net revenues for the full 2026 fiscal year compared with...
NasdaqGS:INDB
NasdaqGS:INDBBanks

3 Financial Stocks With Higher Rate Tailwinds Investors May Want To Research

With Fed Chair Kevin Warsh talking tougher on inflation and bond yields climbing, higher interest rates are reshaping the outlook for global large cap banks and diversified financials. That shift can change how these stocks earn money, reward patient investors or expose weak spots. This article looks at three stocks from the Global Large Cap Banks and Diversified Financials screener that appear positively exposed to the latest rate shock and explains why each one deserves a closer look...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

Atlanta Braves Holdings (BATR.K) Could Be 16% Below Fair Value On Rising MLB Team Valuations

Recent commentary points to rising valuations for rival Major League Baseball teams, which has drawn fresh attention to Atlanta Braves Holdings (BATR.K), the league’s only publicly traded franchise and a direct way to track this sector-wide repricing. At a share price of $50.21, Atlanta Braves Holdings has had a mixed short term run, with a 1-day share price return of 1.27% but a 7-day share price return that fell 5.21%. The year-to-date share price return of 25.97% and 5-year total...
NYSE:EVTC
NYSE:EVTCDiversified Financial

EVERTEC (EVTC) Draws Fresh Attention On Rising Earnings Views And An Undervalued Narrative

Recent coverage around EVERTEC (EVTC) has centered on a more positive earnings outlook and a favorable Zacks Rank, combined with valuation metrics that suggest the stock trades at a discount to its industry peers. Over the past year, EVERTEC’s share price has been volatile. A strong 90 day share price return of 29.2% contrasts with weaker recent moves, including a 1 day decline of 1.6% and a 30 day share price return down 4.2%. The 1 year total shareholder return is down 15.8%, and longer...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

Why Merit Medical Systems (MMSI) Is Getting Fresh Attention

Why this leadership change matters for Merit Medical Systems stock Merit Medical Systems (MMSI) drew fresh investor attention after announcing that Sheri Lewis will become Executive Vice President of Global Operations, with long-serving operations leader Mr. Peterson shifting into a Senior Advisor role. Merit Medical Systems shares trade at US$90.68, with a 30 day share price return of 6.67% and a 90 day share price return of 49.51%. Total shareholder return over three years is 41.91% and...
NYSE:BG
NYSE:BGFood

Is Bunge (BG) Using Sugar Mill Sales To Sharpen Its Core Agribusiness Focus?

Bunge Global has agreed to sell the Rio Vermelho and Nova Unialco sugarcane mills in São Paulo, Brazil, to COFCO International, with the deal still subject to customary closing conditions and regulatory approvals. This divestment reflects Bunge’s effort to refine its post-Viterra asset mix by exiting non-core sugar operations and reinforcing focus on its core agricultural and food supply businesses. We’ll now examine how exiting these Brazilian sugarcane mills could influence Bunge Global’s...
NYSE:PAGS
NYSE:PAGSDiversified Financial

Does PagSeguro’s Shift To an Independent Chair Reshape Its Governance Story for PagSeguro Digital (PAGS)?

PagSeguro Digital Ltd. reported that on August 21, 2026, founder and indirect controlling shareholder Luis Frias stepped down as Director and Chairman, with existing director Maria Judith de Brito assuming the Chair and Eduardo Alcaro reconfirmed as Vice-Chairman. The shift from founder-led board leadership to an independent Chair alters the company’s governance balance while Frias maintains control as majority owner. Now we’ll assess how Maria Judith de Brito’s appointment as Chair may...
NasdaqGS:GLBE
NasdaqGS:GLBEMultiline Retail

3 Stocks To Watch As Trade Shifts Reshape Sanmina, Global E Online And Flex

Global markets are being pulled in different directions as energy supply risks, softer central bank signals and fragile trade talks all hit headlines at once. That mix is creating sharp moves in globally exposed stocks, which can open interesting entry points or caution flags for long term investors. This article walks through three stocks from our Global Trade Exposed Equities screener that are closely tied to these developments and may warrant closer review by investors now. The three...
NasdaqGS:WMG
NasdaqGS:WMGEntertainment

Where Does Warner Music Group (WMG) Valuation Sit Following Its Q2 Earnings Beat?

What sparked the latest move in Warner Music Group stock Warner Music Group (WMG) recently reported Q2 results with revenue, earnings per share and EBITDA all coming in ahead of analyst expectations. The stock has climbed since the earnings release, drawing fresh attention from investors. At a share price of US$27.97, Warner Music Group has given investors a mixed ride, with a 30 day share price return of about 8% contrasting with a year to date decline of around 8% and a 1 year total...
NYSE:ARMK
NYSE:ARMKHospitality

Should Aramark’s (ARMK) Bigger College Footprint Reframe Its Long‑Term Campus Services Strategy?

In August 2026, Aramark announced it had expanded its collegiate footprint through new partnerships with Florida State University and Texas State University, integrating Sports + Entertainment and Collegiate Hospitality to upgrade game-day experiences, campus dining, and performance nutrition across venues and athlete facilities. This push deeper into higher education, where Aramark already serves about 300 colleges and universities and 47 NCAA athletic departments, underscores how scale and...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Is Intuitive Machines (LUNR) Still Below Fair Value After Its New IM 300 Contract?

Intuitive Machines (LUNR) recently announced a contract to build two IM 300 series spacecraft platforms for a new undisclosed customer. The award broadens its IM 300 customer base and highlights demand for modular, mission-configurable satellites. The new IM 300 contract comes after a sharp swing in Intuitive Machines’ share price. The stock is down 11.33% over the past week, even after a 19.29% gain over the past 30 days, while the 1-year total shareholder return of 69% points to strong...